Showing 1 - 20 results of 9,186 for search '(( brain ((surgery decrease) OR (largest decrease)) ) OR ( _ rare increased ))', query time: 0.47s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Does Decreased SNX10 Serve as a Novel Risk Factor in Atrial Fibrillation of the Valvular Heart Disease? - A Case-Control Study by Jianping Yao (5153537)

    Published 2021
    “…SNX10 expression was negatively associated with the degree of fibrosis (P=0.017, Spearman rho=-0.447), the New York Heart Association degree (P=0.003, Spearman rho=-0.545), left atrial diameter (P=0.038, Spearman rho=-0.393), right atrial diameter (P=0.043, Spearman rho=-0.386), and the brain natriuretic peptide (BNP) level 24 hours after surgery (P=0.030, Spearman rho=-0.426), but not the BNP level before surgery and 72 hours after surgery. …”
  5. 5
  6. 6
  7. 7
  8. 8

    A tailored approach to fusion transcript identification increases diagnosis of rare inherited disease by Gavin R. Oliver (7456514)

    Published 2019
    “…<div><p>Background</p><p>RNA sequencing has been proposed as a means of increasing diagnostic rates in studies of undiagnosed rare inherited disease. …”
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Video_1_Confocal-Assisted Multispectral Fluorescent Microscopy for Brain Tumor Surgery.MPG by Patra Charalampaki (149064)

    Published 2019
    “…In the last decade, the development of fluorescence-guided surgery has been the most influential breakthrough, marginally improving outcomes in brain tumor surgery. …”
  15. 15

    Dataset of manuscript entitled: Increasing rare earth extraction kinetics by tailored magnetic fields (Communication Physics) by Zhe Lei (22404280)

    Published 2025
    “…<p dir="ltr">Dataset of manuscript entitled: Increasing rare earth extraction kinetics by tailored magnetic fields. …”
  16. 16
  17. 17
  18. 18

    A Rare Variant in Metallothionein 1E Increases the Risk for Type 2 Diabetes in a Chinese Population by Xiantong Zou (16861311)

    Published 2023
    “…<p dir="ltr">Objective: To uncover novel targets for the treatment of type 2 diabetes (T2D) by investigating rare variants with large effects in monogenic forms of the disease.…”
  19. 19
  20. 20